Cargando…
Pyruvate Dehydrogenase Complex and Glucose Oxidation as a Therapeutic Target in Diabetic Heart Disease
Diabetic cardiomyopathy was originally described as the presence of ventricular dysfunction in the absence of coronary artery disease and/or hypertension. It is characterized by diastolic dysfunction and is more prevalent in people with diabetes than originally realized, leading to the suggestion in...
Autores principales: | Tabatabaei Dakhili, Seyed Amirhossein, Greenwell, Amanda A., Ussher, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884548/ https://www.ncbi.nlm.nih.gov/pubmed/36761067 http://dx.doi.org/10.12997/jla.2023.12.1.47 |
Ejemplares similares
-
Myocardial disturbances of intermediary metabolism in Barth syndrome
por: Greenwell, Amanda A., et al.
Publicado: (2022) -
Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome
por: Greenwell, Amanda A., et al.
Publicado: (2022) -
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
por: Gopal, Keshav, et al.
Publicado: (2018) -
Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
por: Jeoung, Nam Ho
Publicado: (2015) -
Role of the Pyruvate Dehydrogenase Complex in Metabolic Remodeling: Differential Pyruvate Dehydrogenase Complex Functions in Metabolism
por: Park, Sungmi, et al.
Publicado: (2018)